相关实验视频

Updated: Jul 25, 2025

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice

Published on: June 30, 2021

ATP13A4上调驱动乳腺癌细胞系MCF7中的高聚胺运输系统

Sarah van Veen¹, Antria Kourti¹, Elke Ausloos¹

¹Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.

|June 28, 2023

概括

研究人员确定ATP13A4是一种新型聚胺转运体,有助于乳腺癌细胞中聚胺水平升高. 这一发现突出了ATP13A4作为新型抗癌药物阻断聚胺运输系统的潜在治疗点.

科学领域:

生物化学生物化学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

聚胺稳态非常重要,在癌症等疾病中经常被破坏,这种疾病的特点是细胞内聚胺水平高和增强的聚胺运输系统 (PTS).
鉴定癌细胞中高聚胺吸收的特定聚胺转运体对于开发向疗法至关重要,因为正在探索聚胺转运抑制剂用于癌症治疗.

研究的目的:

调查P5B运输ATPase家族成员是否与非瘤源的MCF10A细胞相比,在MCF7乳腺癌细胞中对上调的PTS有所贡献.
描述ATP13A4,一种P5B-ATPase在聚胺运输中的作用及其对癌细胞表型的贡献.

主要方法:

在MCF7和MCF10A细胞系中对聚胺转运体表达的比较分析.
使用BODIPY标记的聚氨酸测量聚氨酸吸收的功能测定.
细胞活力,细胞死亡和克隆原性测试以评估聚胺细胞毒性.
在MCF10A细胞中过度表达ATP13A4的研究,以模仿癌细胞表型.

主要成果:

在MCF7细胞中,ATP13A4的表达显著增加,这是以前未被描述的P5B-ATPase.
鉴定出ATP13A4是负责MCF7细胞中聚胺吸收活性增加的载体.
MCF7细胞对聚胺诱导的细胞毒性表现出更高的敏感性.
在MCF10A细胞中过度表达ATP13A4,复制了在MCF7细胞中观察到的高聚胺吸收和对毒性的敏感性增加.

结论:

在人类PTS中,ATP13A4被确立为一种新型的多胺载体.
ATP13A4在乳腺癌细胞特征的多胺吸收增加中发挥着重要作用.
ATP13A4代表了开发抑制PTS的抗癌药物的有前途的治疗标.

关键词:

在 ATP13A4 中,P5B类型的ATP酶.癌症癌症癌症癌症癌症哺乳动物聚胺运输系统

更多相关视频

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...